Video Assisted Study of Salbutamol Response in Viral Wheezing
Launched by UNIVERSITY OF OULU · Oct 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a medication called salbutamol helps young children who are experiencing wheezing due to viral infections. Wheezing is a common breathing problem that can make it hard for kids to breathe comfortably. The trial is specifically looking at children aged 6 to 24 months who have been prescribed salbutamol in the emergency department to see how effective it is for them.
To participate in this study, children must be experiencing wheezing and have been given salbutamol as treatment. However, children who need immediate life-saving care, are being transferred to intensive care, or have signs of pneumonia or a foreign object in their airway cannot join. If eligible, participants will take part in a video-assisted study where their response to the medication will be closely monitored. This research aims to improve our understanding of how salbutamol works for young kids with wheezing, ultimately helping doctors provide better care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Wheezing
- • Salbutamol-treatment in emergency department prescribed
- Exclusion Criteria:
- • Need for immediate resuscitation
- • Immediate transfer to ICU
- • Suspicion of pneumonia based on the auscultation finding
- • Suspicion of airway foreign body
About University Of Oulu
The University of Oulu, located in Finland, is a leading research institution known for its commitment to advancing scientific knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the University of Oulu leverages its extensive academic expertise, state-of-the-art facilities, and collaborative networks to conduct rigorous and ethically sound clinical research. The university emphasizes interdisciplinary approaches and strives to translate research findings into practical applications that improve patient outcomes and contribute to public health. Through its clinical trials, the University of Oulu aims to foster advancements in medical science while adhering to the highest standards of integrity and compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oulu, , Finland
Patients applied
Trial Officials
Terhi Tapiainen, Professor
Principal Investigator
University of Oulu
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported